cancer cytopathology

[1] Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology.

[2] The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review

[3] A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.

[4] Endobronchial Pseudocarcinomatous Hyperplasia Mimicking Squamous Cell Carcinoma Associated with Primary Pulmonary ALK-negative Anaplastic Large Cell Lymphoma.

[5] Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology.

[6] Correction: Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor (Journal of Medicinal Chemistry (2016) 59: 7 (3392-3408) DOI: 10.1021/acs.jmedchem.6b00064)

[7] Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer.

[8] Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK-positive anaplastic large-cell lymphoma refractory to chemotherapy and brentuximab vedotin.

[9] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

[10] Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma

[11] Anaplastic progression in low grade glioneural neoplasms

[12] assessment of the potential diagnostic role of anaplastic lymphoma kinase for inflammatory myofibroblastic tumours: a meta-analysis.

[13] anaplastic transformation of papillary thyroid cancer in the retroperitoneum

[14] evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma

[15] primary cutaneous anaplastic large-cell lymphoma: complete remission for 13 years after denileukin diftitox

[16] primary pulmonary anaplastic large cell lymphoma: a rare malignancy and rare cause of the luftsichel sign

[17] pathobiology of anaplastic large cell lymphoma

[18] aggressive multimodal approach for anaplastic thyroid cancer and long-term survival

[19] airway management during anesthesia for stereotactic placement of intratumoral drug delivery system in a patient with anaplastic astrocytoma

[20] infectious mimicry complicates diagnosis in hemophagocytic syndrome caused by anaplastic large-cell lymphoma

[21] primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology?

[22] malignant trigeminal nerve sheath tumor and anaplastic astrocytoma collision tumor with high proliferative activity and tumor suppressor p53 expression

[23] small cell anaplastic carcinoma of primary lung tumor in a miniature schnauzer dog

[24] leukemic phase of pediatric anaplastic large cell lymphoma with unusual immuno-profile and cytogenetic correlation

[25] molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type i insulin-like growth factor receptor